Specific detection of human BK polyomavirus in urine samples of immunocompromised patients

Carol J. Holman, Jo Anne H. Van Burik, Steven H. Hinrichs, Henry H. Balfour

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A semiquantitative PCR assay for the detection of BK virus in urine was developed using primers for BK virus that specifically amplified BK but not JC virus. DNA was extracted from urine through treatment with proteinase K followed by DNA precipitation with sodium acetate. Semiquantitation was achieved by amplifying serial dilutions (1:1, 1:10, 1:100, and 1:1,000) of the urine specimens. Each assay included both positive (stock BK virus and previously positive patient urine) and negative (no template) controls. A urine sample was interpreted as positive if any of the serial dilutions showed amplification of the DNA fragment of the expected size. For some patient-derived samples, amplification of the expected-size fragment was achieved with a dilute template whereas no amplification was achieved with a concentrated template. This was attributed to interfering substances in the urine. PCR results were compared with urine cytology and shown to be more sensitive. Validation studies were performed at the University of Nebraska Medical Center, utilizing a separate qualitative PCR assay that detects both BK and JC virus and distinguishes between them by restriction enzyme digestion patterns. Of 46 urine samples analyzed using both methods, 22 were positive by both assays, 18 were negative by both assays, 5 were positive only by the Nebraska method, and 1 was positive only by our method. In comparison with the Nebraska PCR, our PCR assay had a sensitivity of 81% and specificity of 95%. For twenty-one (43%) of 49 immunocompromised patients, tests were postive when specimens were submitted because of clinical suspicion of BK virus infection.

Original languageEnglish (US)
Pages (from-to)66-69
Number of pages4
JournalClinical and diagnostic laboratory immunology
Volume10
Issue number1
DOIs
StatePublished - Jan 2003

Fingerprint

BK Virus
Immunocompromised Host
Viruses
Assays
Urine
Amplification
Polymerase Chain Reaction
JC Virus
Dilution
DNA
Cytology
Sodium Acetate
Endopeptidase K
Validation Studies
Virus Diseases
Cell Biology
Digestion
Enzymes
Sensitivity and Specificity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this

Specific detection of human BK polyomavirus in urine samples of immunocompromised patients. / Holman, Carol J.; Van Burik, Jo Anne H.; Hinrichs, Steven H.; Balfour, Henry H.

In: Clinical and diagnostic laboratory immunology, Vol. 10, No. 1, 01.2003, p. 66-69.

Research output: Contribution to journalArticle

@article{9230c8ac150843eb99417f79b72229e6,
title = "Specific detection of human BK polyomavirus in urine samples of immunocompromised patients",
abstract = "A semiquantitative PCR assay for the detection of BK virus in urine was developed using primers for BK virus that specifically amplified BK but not JC virus. DNA was extracted from urine through treatment with proteinase K followed by DNA precipitation with sodium acetate. Semiquantitation was achieved by amplifying serial dilutions (1:1, 1:10, 1:100, and 1:1,000) of the urine specimens. Each assay included both positive (stock BK virus and previously positive patient urine) and negative (no template) controls. A urine sample was interpreted as positive if any of the serial dilutions showed amplification of the DNA fragment of the expected size. For some patient-derived samples, amplification of the expected-size fragment was achieved with a dilute template whereas no amplification was achieved with a concentrated template. This was attributed to interfering substances in the urine. PCR results were compared with urine cytology and shown to be more sensitive. Validation studies were performed at the University of Nebraska Medical Center, utilizing a separate qualitative PCR assay that detects both BK and JC virus and distinguishes between them by restriction enzyme digestion patterns. Of 46 urine samples analyzed using both methods, 22 were positive by both assays, 18 were negative by both assays, 5 were positive only by the Nebraska method, and 1 was positive only by our method. In comparison with the Nebraska PCR, our PCR assay had a sensitivity of 81{\%} and specificity of 95{\%}. For twenty-one (43{\%}) of 49 immunocompromised patients, tests were postive when specimens were submitted because of clinical suspicion of BK virus infection.",
author = "Holman, {Carol J.} and {Van Burik}, {Jo Anne H.} and Hinrichs, {Steven H.} and Balfour, {Henry H.}",
year = "2003",
month = "1",
doi = "10.1128/CDLI.10.1.66-69.2003",
language = "English (US)",
volume = "10",
pages = "66--69",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Specific detection of human BK polyomavirus in urine samples of immunocompromised patients

AU - Holman, Carol J.

AU - Van Burik, Jo Anne H.

AU - Hinrichs, Steven H.

AU - Balfour, Henry H.

PY - 2003/1

Y1 - 2003/1

N2 - A semiquantitative PCR assay for the detection of BK virus in urine was developed using primers for BK virus that specifically amplified BK but not JC virus. DNA was extracted from urine through treatment with proteinase K followed by DNA precipitation with sodium acetate. Semiquantitation was achieved by amplifying serial dilutions (1:1, 1:10, 1:100, and 1:1,000) of the urine specimens. Each assay included both positive (stock BK virus and previously positive patient urine) and negative (no template) controls. A urine sample was interpreted as positive if any of the serial dilutions showed amplification of the DNA fragment of the expected size. For some patient-derived samples, amplification of the expected-size fragment was achieved with a dilute template whereas no amplification was achieved with a concentrated template. This was attributed to interfering substances in the urine. PCR results were compared with urine cytology and shown to be more sensitive. Validation studies were performed at the University of Nebraska Medical Center, utilizing a separate qualitative PCR assay that detects both BK and JC virus and distinguishes between them by restriction enzyme digestion patterns. Of 46 urine samples analyzed using both methods, 22 were positive by both assays, 18 were negative by both assays, 5 were positive only by the Nebraska method, and 1 was positive only by our method. In comparison with the Nebraska PCR, our PCR assay had a sensitivity of 81% and specificity of 95%. For twenty-one (43%) of 49 immunocompromised patients, tests were postive when specimens were submitted because of clinical suspicion of BK virus infection.

AB - A semiquantitative PCR assay for the detection of BK virus in urine was developed using primers for BK virus that specifically amplified BK but not JC virus. DNA was extracted from urine through treatment with proteinase K followed by DNA precipitation with sodium acetate. Semiquantitation was achieved by amplifying serial dilutions (1:1, 1:10, 1:100, and 1:1,000) of the urine specimens. Each assay included both positive (stock BK virus and previously positive patient urine) and negative (no template) controls. A urine sample was interpreted as positive if any of the serial dilutions showed amplification of the DNA fragment of the expected size. For some patient-derived samples, amplification of the expected-size fragment was achieved with a dilute template whereas no amplification was achieved with a concentrated template. This was attributed to interfering substances in the urine. PCR results were compared with urine cytology and shown to be more sensitive. Validation studies were performed at the University of Nebraska Medical Center, utilizing a separate qualitative PCR assay that detects both BK and JC virus and distinguishes between them by restriction enzyme digestion patterns. Of 46 urine samples analyzed using both methods, 22 were positive by both assays, 18 were negative by both assays, 5 were positive only by the Nebraska method, and 1 was positive only by our method. In comparison with the Nebraska PCR, our PCR assay had a sensitivity of 81% and specificity of 95%. For twenty-one (43%) of 49 immunocompromised patients, tests were postive when specimens were submitted because of clinical suspicion of BK virus infection.

UR - http://www.scopus.com/inward/record.url?scp=0037246735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037246735&partnerID=8YFLogxK

U2 - 10.1128/CDLI.10.1.66-69.2003

DO - 10.1128/CDLI.10.1.66-69.2003

M3 - Article

C2 - 12522041

AN - SCOPUS:0037246735

VL - 10

SP - 66

EP - 69

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 1

ER -